Statistical Approach To Estimate Vaccinia-Specific Neutralizing Antibody Titers Using a High-Throughput Assay
Open Access
- 1 August 2009
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 16 (8) , 1105-1112
- https://doi.org/10.1128/cvi.00109-09
Abstract
Because of the bioterrorism threat posed by agents such as variola virus, considerable time, resources, and effort have been devoted to biodefense preparation. One avenue of this research has been the development of rapid, sensitive, high-throughput assays to validate immune responses to poxviruses. Here we describe the adaptation of a β-galactosidase reporter-based vaccinia virus neutralization assay to large-scale use in a study that included over 1,000 subjects. We also describe the statistical methods involved in analyzing the large quantity of data generated. The assay and its associated methods should prove useful tools in monitoring immune responses to next-generation smallpox vaccines, studying poxvirus immunity, and evaluating therapeutic agents such as vaccinia virus immune globulin.Keywords
This publication has 52 references indexed in Scilit:
- Immunity from Smallpox Vaccine Persists for Decades: A Longitudinal StudyPublished by Elsevier ,2008
- Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and DryvaxJournal of General Virology, 2008
- Differential Antigen Requirements for Protection against Systemic and Intranasal Vaccinia Virus Challenges in MiceJournal of Virology, 2008
- Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodiesBiologicals, 2008
- Immunity and immunological memory following smallpox vaccinationImmunological Reviews, 2006
- Clinical and Immunological Comparison of Smallpox Vaccine Administered to the Outer versus the Inner Upper Arms of Vaccinia-Naive AdultsClinical Infectious Diseases, 2006
- Smallpox vaccines: from first to second to third generationThe Lancet, 2005
- Development of a Novel Vaccinia‐Neutralization Assay Based on Reporter‐Gene ExpressionThe Journal of Infectious Diseases, 2003
- A Tetrazolium-Based Colorimetric Assay for Titration of Neutralizing Antibodies against Vaccinia VirusViral Immunology, 1998
- Impaired defense against vaccinia in a child with T-lymphocyte deficiency associated with inosine phosphorylase defectThe Journal of Pediatrics, 1978